glp 1 after breast cancer A trio of large observational studies reported at the San Antonio Symposium (SABCS) 2025 suggest that GLP-1 receptor agonists may improve outcomes in some women with breast cancer. Two studies SEOUpdate6 Option:30 Count (Pack of 1) Cardiovascular and mortality outcomes

glp 1 after breast cancer A trio of large observational studies reported at the San Antonio Symposium (SABCS) 2025 suggest that GLP-1 receptor agonists may improve outcomes in some women with breast cancer. Two studies SEOUpdate6 Option:30 Count (Pack of 1) Cardiovascular and mortality outcomes

Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia | Springer Nature Link

Distinct neural sites of GLP‐1R expression mediate physiological versus pharmacological control of Incretin action

SEOUpdate6

Option:30 Count (Pack of 1)

At baseline, 64% patients were classified as NYHA class II, 35% class III and 1% class IV, median LVEF was 32%